Cholera toxin inhibits human hepatocarcinoma cell proliferation in vitro via suppressing ATX/LPA axis

Acta Pharmacologica Sinica

Volumn 32, Issue 8, 2011, Pages 1055-1062

  Xia, Qi ^a   Deng, An Mei ^b   Wu, Shan Shan ^a   Zheng, Min ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

autotaxin; cell proliferation; cholera toxin; hepatocarcinoma; lysophosphatidic acid

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AUTOTAXIN; CHOLERA TOXIN; INTERLEUKIN 10; INTERLEUKIN 4; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL THERAPY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLERA TOXIN; HUMANS; LIVER NEOPLASMS; LYSOPHOSPHOLIPIDS; PHOSPHORIC DIESTER HYDROLASES;

EID: 80051525755     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.31     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
2. Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD. Hepatocellular carcinoma: Current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009; 3: 353-67.
3. Greten TF, Korangy F, Manns MP, Malek NP. Molecular therapy for the treatment of hepatocellular carcinoma. Br J Cancer 2009; 100: 19-23.
4. Braicu C, Burz C, Berindan-Neagoe I, Balacescu O, Graur F, Cristea V, et al. Hepatocellular carcinoma: Tumorigenesis and prediction markers. Gastroenterol Res 2009; 2: 191-9.
5. Cooper AB, Wu J, Lu D, Maluccio MA. Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer? J Gastrointest Surg 2007; 11: 1628-34.
6. Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 1992; 267: 2524-9.
7. Kishi Y, Okudaira S, Tanaka M, Hama K, Shida D, Kitayama J, et al. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J Biol Chem 2006; 281: 17492-500.
8. Black EJ, Clair T, Delrow J, Neiman P, Gillespie DA. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun. Oncogene 2004; 23: 2357-66. (Pubitemid 38496791)
9. Hama K, Aoki J, Fukaya M, Kishi Y, Sakai T, Suzuki R, et al. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem 2004; 279: 17634-9. (Pubitemid 38560528)
10. Wu JM, Xu Y, Skill NJ, Sheng H, Zhao Z, Yu M, et al. Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma. Mol Cancer; 2010; 9: 71.
11. Goodman L, Segreti J. Infectious diarrhea. Dis Mon 1999; 45: 268-99.
12. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. Nature 1981; 292: 413-17. (Pubitemid 11013851)
13. Guerrant RL, Fang GD, Thielman NM, Fonteles MC. Role of platelet activating factor in the intestinal epithelial secretory and Chinese hamster ovary cell cytoskeletal responses to cholera toxin. Proc Natl Acad Sci U S A 1994; 91: 9655-8. (Pubitemid 24297974)
14. Taylor-Papadimitriou J, Purkis P, Fentiman IS. Cholera toxin and analogues of cyclic AMP stimulate the growth of cultured human mammary epithelial cells. J Cell Physiol 1980; 102: 317-21. (Pubitemid 11111639)
15. Lechner JF, Haugen A, Autrup H, McClendon IA, Trump BF, Harris CC. Clonal growth of epithelial cells from normal adult human bronchus. Cancer Res 1981; 41: 2294-304. (Pubitemid 11111432)
16. Cho-Chung YS, Clair T, Shepheard C, Berghoffer B. Arrest of hormonedependent mammary cancer growth in vivo and in vitro by cholera toxin. Cancer Res 1983; 43: 1473-6. (Pubitemid 13122533)
17. Viallet J, Sharoni Y, Frucht H, Jensen RT, Minna JD, Sausville EA. Cholera toxin inhibits signal transduction by several mitogens and the in vitro growth of human small-cell lung cancer. J Clin Invest 1990; 86: 1904-12.
18. Xiao Y, Chen Y, Kennedy AW, Belinson J, Xu Y. Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses. Ann N Y Acad Sci 2000; 905: 242-59. (Pubitemid 30255422)
19. Zhao Z, Xiao Y, Elson P, Tan H, Plummer SJ, Berk M, et al. Plasma lysophosphatidylcholine levels: Potential biomarkers for colorectal cancer. J Clin Oncol 2007; 25: 2696-701. (Pubitemid 47123176)
20. Kehlen A, Lauterbach R, Santos AN, Thiele K, Kabisch U, Weber E, et al. IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA). Clin Exp Immunol 2001; 123: 147-54. (Pubitemid 32118851)
21. Wullaert A, van Loo G, Heyninck K, Beyaert R. Hepatic tumor necrosis factor signaling and nuclear factor-kappaB: Effects on liver homeostasis and beyond. Endocr Rev 2007; 28: 365-86. (Pubitemid 46984825)
22. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 2002; 158: 227-33.
23. Morris AJ, Smyth SS. Measurement of autotaxin/lysophospholipase D activity. Methods Enzymol 2007; 434: 89-104.
24. Lee HY, Clair T, Mulvaney PT, Woodhouse EC, Aznavoorian S, Liotta LA, et al. Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin. J Biol Chem 1996; 271: 24408-12. (Pubitemid 26333173)
25. Nam SW, Clair T, Campo CK, Lee HY, Liotta LA, Stracke ML. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 2000; 19: 241-7. (Pubitemid 30077220)
26. Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA, et al. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res 2001; 61: 6938-44. (Pubitemid 32896522)
27. Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, Kon J, et al. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol Pharmacol 2003; 64: 994-1005. (Pubitemid 37153068)
28. Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, Han JW, et al. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene 2011; 30: 1351-9.